Citation: Pe. Wallemacq et Rk. Verbeeck, Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients, CLIN PHARMA, 40(4), 2001, pp. 283-295
Authors:
Buysschaert, M
Wallemacq, PE
Dramais, AS
Hermans, MP
Citation: M. Buysschaert et al., Hyperhomocysteinemia in type 2 diabetes - Relationship to macroangiopathy,nephropathy, and insulin resistance, DIABET CARE, 23(12), 2000, pp. 1816-1822
Authors:
Mourad, M
Chaib-Eddour, D
Malaise, J
Konig, J
Squifflet, JP
Wallemacq, PE
Citation: M. Mourad et al., Analytical and clinical evaluation of the EMIT mycophenolic acid immunoassay in kidney transplantation, TRANSPLAN P, 32(2), 2000, pp. 404-406
Citation: Pe. Wallemacq et K. Alexandre, Evaluation of the new AxSYM cyclosporine assay: Comparison with TDx monoclonal whole blood and emit cyclosporine assays, CLIN CHEM, 45(3), 1999, pp. 432-435
Authors:
Brau, M
Vanbinst, R
Hassoun, A
Wallemacq, PE
Citation: M. Brau et al., Simultaneous detection and quantification of acidic and basic drugs in serum toxicological screening: Use of ion-pairing technique in liquid-liquid extraction, ACT CLIN B, 1999, pp. 74-78